A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy
Clinical trial NCT00216541 · COMPLETED
Trial details
- NCT number
- NCT00216541
- Sponsor
- Janssen-Cilag B.V.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-08-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.